去污染策略与机械通气患者耐药菌血流感染:随机临床试验
在13个中高耐药ICU中,将8665例机械通气患者按随机顺序接受2%氯己定漱口、选择性口咽去污染(SOD)或选择性消化道去污染(SDD)与基线比较;三种干预均未显著降低ICU获得性多重耐药革兰阴性菌血流感染,28天死亡率也无显著差异。
要点
- 在抗生素耐药中高流行ICU,CHX漱口、SOD或SDD未显著减少MDRGNB血流感染。
- SDD组绝对风险降低0.8%(95%CI 0.1%-1.6%),但校正后风险比无统计学意义。
- 三种干预均未显著改善28天死亡率。
核心结论
- 在中高抗生素耐药ICU的机械通气患者中,CHX漱口、SOD或SDD与标准护理相比未显著降低MDRGNB血流感染发生率。
主要发现
- ICU获得性MDRGNB血流感染在基线、CHX、SOD和SDD期的发生率分别为2.1%、1.8%、1.5%和1.2%。
- 与基线相比,CHX、SOD和SDD的绝对风险降低分别为0.3%(95%CI -0.6%至1.1%)、0.6%(95%CI -0.2%至1.4%)和0.8%(95%CI 0.1%至1.6%)。
- 校正后风险比分别为1.13(95%CI 0.68-1.88)、0.89(95%CI 0.55-1.45)和0.70(95%CI 0.43-1.14)。
- 28天粗死亡率在基线、CHX、SOD和SDD期分别为31.9%、32.9%、32.4%和34.1%。
- 28天死亡率校正后比值比分别为1.07(95%CI 0.86-1.32)、1.05(95%CI 0.85-1.29)和1.03(95%CI 0.80-1.32)。
临床怎么用
- 在中高耐药ICU中,不应常规使用CHX漱口、SOD或SDD来降低MDRGNB血流感染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The effects of chlorhexidine (CHX) mouthwash, selective oropharyngeal decontamination (SOD), and selective digestive tract decontamination (SDD) on patient outcomes in ICUs with moderate to high levels of antibiotic resistance are unknown. OBJECTIVE: To determine associations between CHX 2%, SOD, and SDD and the occurrence of ICU-acquired bloodstream infections with multidrug-resistant gram-negative bacteria (MDRGNB) and 28-day mortality in ICUs with moderate to high levels of antibiotic resistance. DESIGN, SETTING, AND PARTICIPANTS: Randomized trial conducted from December 1, 2013, to May 31, 2017, in 13 European ICUs where at least 5% of bloodstream infections are caused by extended-spectrum β-lactamase-producing Enterobacteriaceae. Patients with anticipated mechanical ventilation of more than 24 hours were eligible. The final date of follow-up was September 20, 2017. INTERVENTIONS: Standard care was daily CHX 2% body washings and a hand hygiene improvement program. Following a baseline period from 6 to 14 months, each ICU was assigned in random order to 3 separate 6-month intervention periods with either CHX 2% mouthwash, SOD (mouthpaste with colistin, tobramycin, and nystatin), or SDD (the same mouthpaste and gastrointestinal suspension with the same antibiotics), all applied 4 times daily. MAIN OUTCOMES AND MEASURES: The occurrence of ICU-acquired bloodstream infection with MDRGNB (primary outcome) and 28-day mortality (secondary outcome) during each intervention period compared with the baseline period. RESULTS: A total of 8665 patients (median age, 64.1 years; 5561 men [64.2%]) were included in the study (2251, 2108, 2224, and 2082 in the baseline, CHX, SOD, and SDD periods, respectively). ICU-acquired bloodstream infection with MDRGNB occurred among 144 patients (154 episodes) in 2.1%, 1.8%, 1.5%, and 1.2% of included patients during the baseline, CHX, SOD, and SDD periods, respectively. Absolute risk reductions were 0.3% (95% CI, -0.6% to 1.1%), 0.6% (95% CI, -0.2% to 1.4%), and 0.8% (95% CI, 0.1% to 1.6%) for CHX, SOD, and SDD, respectively, compared with baseline. Adjusted hazard ratios were 1.13 (95% CI, 0.68-1.88), 0.89 (95% CI, 0.55-1.45), and 0.70 (95% CI, 0.43-1.14) during the CHX, SOD, and SDD periods, respectively, vs baseline. Crude mortality risks on day 28 were 31.9%, 32.9%, 32.4%, and 34.1% during the baseline, CHX, SOD, and SDD periods, respectively. Adjusted odds ratios for 28-day mortality were 1.07 (95% CI, 0.86-1.32), 1.05 (95% CI, 0.85-1.29), and 1.03 (95% CI, 0.80-1.32) for CHX, SOD, and SDD, respectively, vs baseline. CONCLUSIONS AND RELEVANCE: Among patients receiving mechanical ventilation in ICUs with moderate to high antibiotic resistance prevalence, use of CHX mouthwash, SOD, or SDD was not associated with reductions in ICU-acquired bloodstream infections caused by MDRGNB compared with standard care. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02208154.
引用
- Wittekamp BH, Plantinga NL, Cooper BS, et al. Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial. JAMA. 2018. PMID: 30347072. doi:10.1001/jama.2018.13765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。